Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Reductions in Funding for Medical Research

Jack L. Arbiser, MD, PhD1
[+] Author Affiliations
1Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
JAMA. 2013;310(8):855-856. doi:10.1001/jama.2013.170797.
Text Size: A A A
Published online


To the Editor Dr Emanuel1 ascribed much of the blame for increasing health care costs to biomedical research, and cited increasing costs as a major reason for the decrease in real dollars for NIH funding. He pointed out that the NIH must demonstrate its ability to lower costs. The true picture is far more complex.

First, Emanuel used bevacizumab as an example of an expensive, noncurative drug. Other examples of noncurative drugs that have had a major effect on health are statins and antiretrovirals. These drugs do not cure coronary artery disease or human immunodeficiency virus but do prolong life. Even the example that Emanuel cited as a triumph, the Hemophilus influenzae type B vaccine, could be seen as increasing costs because individuals saved by this vaccine could eventually develop expensive diseases as the population ages.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




August 28, 2013
Ezekiel J. Emanuel, MD, PhD
1Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia
JAMA. 2013;310(8):856. doi:10.1001/jama.2013.170807.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...